Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Algorithms
New algorithms research has been reported by scientists at Harvard University, Medical Department
April 15th, 2008
According to recent research from the United States, "Because the elderly are underrepresented on clinical trials, physicians have few sources of information to estimate the risks (ie, toxicities) and benefits of chemotherapy administration to the elderly. Our goal was to determine whether the standard measures of toxicity used in clinical trials could be captured from observational Medicare claims data." "We identified 175 elderly clinical trial patients treated on 2 Cancer and Leukemia Group B (CALGB) trials (9344, adjuvant breast study and 9730, advanced lung cancer study) and merged participants' CALGB data with their Medicare data. From CALGB data, we identified...
Source: Cancer Weekly (2008-04-15)
|
